RE
CELG

RBC Europe’s Celgene Corp CELG Stock Holding History

RBC Europe’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,451
Closed -$243K – 1085
2019
Q3 		$243K Hold
2,451
– – 0.02% 218
2019
Q2 		$227K Hold
2,451
– – 0.02% 235
2019
Q1 		$231K Buy
2,451
+100
+4% +$8.75K 0.03% 228
2018
Q4 		$151K Sell
2,351
-876
-27% -$64.7K 0.02% 255
2018
Q3 		$289K Sell
3,227
-566
-15% -$50K 0.03% 207
2018
Q2 		$301K Sell
3,793
-54,638
-94% -$4.54M 0.04% 209
2018
Q1 		$5.21M Sell
58,431
-519
-0.9% -$49.8K 0.64% 36
2017
Q4 		$6.15M Sell
58,950
-1,144
-2% -$129K 0.76% 28
2017
Q3 		$8.76M Buy
+60,094
New +$8.19M 1.15% 24

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

RBC Europe's CELG Position: Q4 2019 in Review

RBC Europe sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,451 shares — an estimated $243K sold.

RBC Europe first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $8.76M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • RBC Europe reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • RBC Europe sold 2,451 Celgene Corp shares in Q4 2019, an estimated $243K.
  • RBC Europe first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
  • RBC Europe's Celgene Corp position peaked at $8.76M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on RBC Europe's 13F filing for Q4 2019, filed 9 Nov 2023.